DTIL Stock Analysis: Buy, Sell, or Hold?
DTIL - Precision BioSciences, Inc. Common Stock
$3.96
-0.02 (-0.63%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 25, 2026
Get Alerted When DTIL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DTIL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: DTIL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: DTIL is currently trading at $3.96, which is considered oversold relative to its 30-day fair value range of $3.99 to $4.25.
Technical Outlook: Technically, DTIL is in a downtrend. Immediate support is located at $3.77, while resistance sits at $4.61.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.50 (+720.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DTIL is in a downtrend. Immediate support is located at $3.77, while resistance sits at $4.61.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.50 (+720.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$3.99 -
$4.25
Company Quality Score
48/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.0%
Protect Your Profits
Holding DTIL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 720.7% below Wall St target ($32.50)
- CAUTION: Recommendation downgraded due to -5.7% 5-day decline
Fair Price Analysis
30-Day Fair Range
$3.99 -
$4.25
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.20
(30.3%)
Support & Resistance Levels
Support Level
$3.77
Resistance Level
$4.61
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.27
Wall Street Target
$32.50
(+720.7%)
Revenue Growth (YoY)
-97.7%
Last updated: February 01, 2026 4:46 AM ET
Data refreshes hourly during market hours. Next update: 5:46 AM
Data refreshes hourly during market hours. Next update: 5:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DTIL showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Stanley Frankel
BUY
2700 shares
2025-09-26
Melinda Brown
BUY
1400 shares
2025-09-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced DTIL Option Strategies
Professional options setups generated by AI based on today's DTIL price and gamma walls.
